Capital Fund Management (CFM)
MRNA icon

Capital Fund Management (CFM)’s Moderna MRNA Stock Holding History

Capital Fund Management (CFM)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Sell
277,758
-292,172
-51% -$15.1M 0.09% 332
2026
Q1 		$29M Sell
569,930
-367,150
-39% -$17.1M 0.13% 196
2025
Q4 		$27.6M Sell
937,080
-238,685
-20% -$6.48M 0.08% 350
2025
Q3 		$30.4M Sell
1,175,765
-221,712
-16% -$6.18M 0.08% 345
2025
Q2 		$38.6M Buy
1,397,477
+895,400
+178% +$23.6M 0.11% 276
2025
Q1 		$14.2M Sell
502,077
-869,481
-63% -$30.9M 0.04% 549
2024
Q4 		$57M Buy
1,371,558
+741,929
+118% +$35.5M 0.15% 200
2024
Q3 		$42.1M Buy
+629,629
New +$57.8M 0.12% 237
2024
Q2 		– Sell
-91,880
Closed -$11.6M – 2068
2024
Q1 		$9.79M Buy
+91,880
New +$9.26M 0.03% 738
2022
Q4 		– Sell
-243,031
Closed -$39.7M – 1539
2022
Q3 		$28.7M Buy
243,031
+207,196
+578% +$31.4M 0.23% 112
2022
Q2 		$5.12M Sell
35,835
-20,419
-36% -$2.92M 0.05% 509
2022
Q1 		$9.69M Buy
56,254
+15,096
+37% +$2.54M 0.08% 343
2021
Q4 		$10.5M Buy
+41,158
New +$12M 0.08% 361
2021
Q2 		– Sell
-206,704
Closed -$36.9M – 1567
2021
Q1 		$27.1M Buy
206,704
+99,775
+93% +$14.5M 0.3% 85
2020
Q4 		$11.2M Buy
+106,929
New +$10.8M 0.11% 235
2020
Q3 		– Sell
-20,702
Closed -$1.33M – 1325
2020
Q2 		$1.33M Buy
+20,702
New +$1.13M 0.02% 621

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Capital Fund Management (CFM)'s MRNA Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Moderna (MRNA) stake by 51% in Q2 2026, selling an estimated $15.1M and leaving 277,758 shares worth $19.5M. The position accounts for 0.09% of the portfolio, ranked #332.

Capital Fund Management (CFM) first reported a position in MRNA in Q2 2020 and has held it in 16 quarters since. The position peaked at $57M in Q4 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Capital Fund Management (CFM) held 277,758 shares of Moderna worth $19.5M as of Q2 2026.
  • Capital Fund Management (CFM) sold 292,172 Moderna shares in Q2 2026, an estimated $15.1M.
  • Moderna made up 0.09% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #332 holding.
  • Capital Fund Management (CFM) first reported a position in Moderna in Q2 2020 and has held it in 16 quarters since.
  • Capital Fund Management (CFM)'s Moderna position peaked at $57M in Q4 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.